These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 11206219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernik S, Mills C, Wallack M, Abdel-Dayem HM.
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer.
    Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Rasoul Zakavi S, Memar B, Naser Forghani M, Mehrabibahar M, Sadeghi R.
    Rev Esp Med Nucl; 2010 Jan; 29(2):73-7. PubMed ID: 19931946
    [Abstract] [Full Text] [Related]

  • 8. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM, Duygun U, Acar E, Daglioz G, Yenjay L, Zekioglu O, Kapkac M.
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [Abstract] [Full Text] [Related]

  • 9. Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
    Pairawan SS, Cora C, Olaya W, Deisch J, Garberoglio R, Solomon N, Senthil M, Garberoglio C, Lum SS.
    Ann Surg Oncol; 2016 Oct; 23(10):3330-6. PubMed ID: 27334213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, Chung M, Watson M, Ota DM.
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [Abstract] [Full Text] [Related]

  • 15. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Chung A, Yu J, Stempel M, Patil S, Cody H, Montgomery L.
    Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M, Bordea C, Blidaru A.
    Chirurgia (Bucur); 2015 Oct; 110(1):26-32. PubMed ID: 25800312
    [Abstract] [Full Text] [Related]

  • 19. Periareolar injection for localization of sentinel nodes in breast cancer patients.
    Ellis RL, Seifert PJ, Neal CE, Pavolka KR, Mann JL, Malafa MP, Wichterman KA, Ross DS, Dunnington GL.
    Breast J; 2004 Oct; 10(2):94-100. PubMed ID: 15009034
    [Abstract] [Full Text] [Related]

  • 20. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.